{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:13:18Z","timestamp":1777443198934,"version":"3.51.4"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":396,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871858"],"award-info":[{"award-number":["81871858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172550"],"award-info":[{"award-number":["82172550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871858"],"award-info":[{"award-number":["81871858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172550"],"award-info":[{"award-number":["82172550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Few studies have focused on the effect of torsemide versus furosemide after discharge on prognosis in patients with heart failure with preserved ejection fraction (HFpEF). This single-centre retrospective real-world study was conducted to evaluate the effect of torsemide versus furosemide after discharge on all-cause mortality and rehospitalization for heart failure in patients with HFpEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive patients who were diagnosis with HFpEF after discharge between January 2015 and April 2018 at the First Affiliated Hospital of Dalian Medical University and who had been treated with torsemide or furosemide were included in this study. The primary outcome was all-cause mortality. The second outcome was rehospitalization for heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 445 patients (mean age 68.56 \u00b1 8.07, female 55%) were divided into the torsemide group (N = 258) or furosemide group (N = 187) based on the treatment course at discharge from the hospital. During a mean follow-up of 87.67 \u00b1 11.15 months, death occurred in 68 of 258 patients (26.36%) in the torsemide group and 60 of 187 patients (30.09%) in the furosemide group [hazard ratio (HR) 0.81, 95% confidence interval (CI) 0.57\u20131.15, P = 0.239]. Rehospitalization for heart failure occurred in 111 of 258 patients (43.02%) in the torsemide groups and 110 of 187 patients (58.82%) in the furosemide group (HR 0.64, 95% CI 0.49\u20130.85, P = 0.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with furosemide, torsemide did not significantly reduce all-cause mortality, but there was association between torsemide and reduced rehospitalization for heart failure in patients with HFpEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15071","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:39:12Z","timestamp":1725590352000},"page":"71-79","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real World Experience in Effect of Torsemide vs. Furosemide After Discharge in Patients with HFpEF"],"prefix":"10.1093","volume":"12","author":[{"given":"Xiao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Si","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Dalian Medical University , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-0800","authenticated-orcid":false,"given":"Danyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Xiangya Hospital, Central South University , Changsha ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2026012113065374400_ehf215071-bib-0001","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/cir.0000000000001052","article-title":"Heart disease and stroke Statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2026012113065374400_ehf215071-bib-0002","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.jacc.2018.03.517","article-title":"Home-time after discharge among patients hospitalized with heart failure","volume":"71","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012113065374400_ehf215071-bib-0003","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113065374400_ehf215071-bib-0004","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjmed.2016.09.012","article-title":"Registries in atrial fibrillation: from trials to real-life clinical practice","volume":"130","author":"Mazurek","year":"2017","journal-title":"Am J Med"},{"key":"2026012113065374400_ehf215071-bib-0005","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113065374400_ehf215071-bib-0006","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012113065374400_ehf215071-bib-0007","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ejhf.2747","article-title":"Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea","volume":"25","author":"Omote","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0008","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"2026012113065374400_ehf215071-bib-0009","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"28","author":"Writing Committee Members; ACC\/AHA Joint Committee Members","year":"2022","journal-title":"J Card Fail"},{"key":"2026012113065374400_ehf215071-bib-0010","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.121.008351","article-title":"Diuretic changes, health care resource utilization, and clinical outcomes for heart failure with reduced ejection fraction: from the Change the Management of Patients With Heart Failure Registry","volume":"14","author":"Khan","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0011","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"2026012113065374400_ehf215071-bib-0012","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cos\u00edn","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0013","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ejhf.960","article-title":"Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)","volume":"20","author":"Trippel","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0014","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of Torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"2026012113065374400_ehf215071-bib-0015","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1002\/ehf2.14467","article-title":"Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation","volume":"10","author":"Baudry","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0016","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/ehf2.14338","article-title":"Association between changes in loop diuretic dose and outcomes in acute heart failure","volume":"10","author":"Seko","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0017","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026012113065374400_ehf215071-bib-0018","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026012113065374400_ehf215071-bib-0019","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/circheartfailure.113.001281","article-title":"Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction","volume":"7","author":"Bello","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0020","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jchf.2014.12.017","article-title":"The hospitalization burden and post-hospitalization mortality risk in heart failure with preserved ejection fraction: results from the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)","volume":"3","author":"Carson","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026012113065374400_ehf215071-bib-0021","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012113065374400_ehf215071-bib-0022","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","article-title":"A reappraisal of loop diuretic choice in heart failure patients","volume":"169","author":"Buggey","year":"2015","journal-title":"Am Heart J"},{"key":"2026012113065374400_ehf215071-bib-0023","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14779072.2022.2022474","article-title":"An evaluation of torsemide in patients with heart failure and renal disease","volume":"20","author":"Peters","year":"2022","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/1\/71\/64513239\/eschf_12_1_71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/1\/71\/64513239\/eschf_12_1_71.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:07:09Z","timestamp":1769018829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/1\/71\/8261864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,5]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15071","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"2024-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}